Delivery Order SPE2DB25D3006-SPE2DB25FXHTB
Award Date 4/4/25
Potential Completion Date 4/7/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,534.57, is for the delivery of EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of July 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,011.30 contract is for the supply of EBGLYSS 250 MG/2 ML PEN 2ML pharmaceutical products. The order is not set aside and is part of AmerisourceBergen's broader $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- This is a $10,744.31 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the pharmaceutical product "EBGLYSS 250 MG/2 ML PEN 2ML" and has a performance period ending on July 10, 2025. This award is not set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a pharmaceutical product, EBGLYSS 250 MG/2 ML PEN 2ML, with a firm fixed price of $1,819.44 and a completion date of June 25, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,294.84, is a Delivery Order for the provision of 4567759998 ! WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of March 12, 2025 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $166,566.12, is a delivery order with a firm fixed price and an ultimate completion date of February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The...
- This federal contract award is a delivery order issued under a larger indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation. The IDC has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This award, valued at $2,731.87, is for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, to support military treatment programs and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.50, is a delivery order for the WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of pharmaceutical products. The contract, valued at $1,053.76, is a Delivery Order with a Firm Fixed Price pricing type. The award has an ultimate completion date of July 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide the DLA with the product "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML". This contract is not designated...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,218.16, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of October 22, 2024 and is structured as a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. AmerisourceBergen holds a...